Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4295540 Target Snapshot

Beta-lactamase NDM-1 · SINGLE PROTEIN · Escherichia coli

17Compounds
52Assays
1Approved Drugs
8.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt E5KIY2. Use UniProt E5KIY2 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt E5KIY2 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Beta-lactamase NDM-1 as ChEMBL target CHEMBL4295540, mapped to UniProt E5KIY2. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Beta-lactamase NDM-1
SINGLE PROTEIN · Escherichia coli
As of 2026-09-14
ChEMBL target ID
CHEMBL4295540
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
E5KIY2
Beta-lactamase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Beta-lactamase NDM-1 is the right protein anchor across sources, using UniProt E5KIY2 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelBeta-lactamase
UniProt AccessionE5KIY2
Component TypeProtein
Sequence Length270 aa

Beta-lactamase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Beta-lactamase NDM-1, mapped to UniProt E5KIY2. ChEMBL maps the protein component as Beta-lactamase. Sequence length is 270 aa.

Mapped IDE5KIY2
Review nameBeta-lactamase NDM-1
OrganismEscherichia coli
Clinical Profile

Clinical Phase Distribution

1
Approved
2
Phase III
Assay Mix

Activity Type Distribution

IC505.0
KI2.0
KD1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2005280 6.96 IC50 109.5 Preclinical
CHEMBL197194 6.47 Kd 337.0 Clinical
CHEMBL2005280 5.29 Ki 5110.0 Preclinical
CHEMBL4212352 5.25 IC50 5624.0 Preclinical
CHEMBL4212352 5.25 Ki 5630.0 Preclinical
CHEMBL1560 5.16 IC50 7000.0 Approved
CHEMBL5396807 5.0 IC50 10000.0 Preclinical
CHEMBL197194 4.86 IC50 13800.0 Clinical
Distribution

pChEMBL Value Distribution

5
5.0
0
5.5
1
6.0
1
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

52
Total Assays
6
Tested Compounds
1
Assay Types
Binding — 52 assays, 6 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 46 5 5.6
assay format 6 1 4.9

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine